SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 370 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 370 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 370 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | +100.0% | 370 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 370 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -66.7% | 370 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $3,000 | 0.0% | 370 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -25.0% | 370 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +33.3% | 370 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -50.0% | 370 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $6,000 | -25.0% | 370 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $8,000 | +33.3% | 370 | 0.0% | 0.00% | +200.0% |
| Q1 2018 | $6,000 | -14.3% | 370 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | – | 370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| Crestline Management, LP | 65,362 | $51,000 | 0.01% |